You know a horror film’s in trouble when the morning-after scene is more satisfying than the “night before.” When the aftermath carries more weight than the chaos. When I spent more time marveling at ...
The average one-year price target for Werewolf Therapeutics (NasdaqGS:HOWL) has been revised to $5.30 / share. This is a decrease of 10.86% from the prior estimate of $5.95 dated December 18, 2025.
Werewolf Therapeutics, Inc. (NASDAQ:HOWL) is included on our list of stocks under $1 that will explode. On December 18, 2025, Werewolf Therapeutics, Inc. (NASDAQ:HOWL) shared a comprehensive pipeline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results